Hülya Dirol, Hakan Keskin, Makbule Ergin

Hemoptizi olan ve olmayan tüberkülozlu hastaların cerrahi tedavi sonuçları

Amaç: Hemoptizi hastalarında uygulanan cerrahi girişimlerin artmış komplikasyon riski cerrahlar arasında yaygın bir endişedir. Bu nedenle burada hemoptizi olan tüberküloz hastalarının cerrahi sonuçlarını araştırdık. Gereç ve yöntem: 1985-2018 yılları arasında cerrahi olarak tüberküloz tanısı alan hastalar retrospektif olarak incelendi. Hastalar iki gruba ayrıldı; hemoptizi olmayanlar (Grup 1) ve hemoptizi olanlar (Grup 2). Analiz yaş, cinsiyet, semptomlar, komorbiditeler, Pozitron Emisyon Tomografisi-Bilgisayarlı Tomografi (PET-CT) bulguları, cerrahi müdahaleler, perioperatif komplikasyonlar, hastanede kalış süreleri, hemoptizi nüksü ve Grup 1 ve 2'nin karşılaştırmasını içeriyordu. Bulgular: Cerrahi olarak teşhis edilen akciğer tüberkülozu olan 541 hasta incelendi. Grup 1'de 448 hasta, Grup 2'de 93 hasta vardı. Grup 2'deki hastalar Grup 1'deki hastalara göre anlamlı olarak daha gençti (Grup 1 ortalama yaş 57,8±6,2, Grup 2 ortalama yaş 31,2±5,3, p

PDF

___

1. Nugent AW, Daubeney PEF, Chondros P, et al. National Australian Childhood Cardiomyopathy Study. The epidemiology of childhood cardiomyopathy in Australia. N Engl J Med 2003;348:1639-1646. https:// doi.org/10.1056/NEJMoa021737
2. Richardson P, McKenna W, Bristow M, et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology task force on the definition and classification of cardiomyopathies. Circulation 1996;93:841-842. https://doi. org/10.1161/01.cir.93.5.841
3. Lipshultz SE, Sleeper LA, Towbin JA, et al. The incidence of pediatric cardiomyopathy in two regions of the United States. N Engl J Med 2003;348:1647-1655. https://doi.org/10.1056/NEJMoa021715
4. Cox GF. Diagnostic approaches to pediatric cardiomyopathy of metabolic genetic etiologies and their relation to therapy. Prog Pediatr Cardiol 2007;24:15- 25. https://doi.org/10.1016/j.ppedcard.2007.08.013
5. Towbin JA, Lowe AM, Colan SD, et al. Incidence, causes, and outcomes of dilated cardiomyopathy in children. JAMA 2006;296:1867-1876. https://doi. org/10.1001/jama.296.15.1867
6. Daubeney PE, Nugent AW, Chondros P, et al. National Australian Childhood Cardiomyopathy Study. Clinical features and outcomes of childhood dilated cardiomyopathy: results from a national populationbased study. Circulation 2006;114:2671-2678. https:// doi.org/10.1161/CIRCULATIONAHA.106.635128
7. Maron BJ, Towbin CJA, Thiene FG, et al. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association scientific statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; quality of care and outcomes research and functional genomics and translational biology interdisciplinary working groups; and council on epidemiology and prevention. Circulation 2006;113:1807-1816. https://doi. org/10.1161/CIRCULATIONAHA.106.174287
8. Naudi D, Rossano JW. Epidemiology and Cost of heart failure in children. Cardiol Young 2015;25:1460-1468. https://doi.org/10.1017/S1047951115002280
9. Puggia I, Merlo M, Barbati G, et al. Natural history of dilated cardiomyopathy in children. J Am Heart Assoc 2016;5:e003450. https://doi.org/10.1161/ JAHA.116.003450
10. Dec GW Jr, Palacios IF, Fallon JT, et al. Active myocarditis in the spectrum of acute dilated cardiomyopathies. Clinical features, histologic correlates, and clinical outcome. N Engl J Med 1985;312:885-890. https://doi. org/10.1056/NEJM198504043121404
11. Lipshultz SE, Law YM, Asante Korang A, et al. Cardiomyopathy in children: classification and diagnosis: a scientific statement from the American Heart Association. Circulation 2019;140:9-68. https:// doi.org/10.1161/CIR.0000000000000682
12. Alvarez JA, Orav EJ, Wilkinson JD, et al. Competing risks for death and cardiac transplantation in children with dilated cardiomyopathy: results from the pediatric cardiomyopathy registry. Circulation 2011;124:814-823. https://doi.org/10.1161/ CIRCULATIONAHA.110.973826
13. Burch M, Siddiqi SA, Celermajer DS, Scott C, Bull C, Deanfield JE. Dilated cardiomyopathy in children: determinants of outcome. Br Heart J 1994;72:246-250. https://doi.org/10.1136/hrt.72.3.246
14. Muller G, Ulmer HE, Hagel KJ, Wolf D. Cardiac dysrhythmias in children with idiopathic dilated or hypertrophic cardiomyopathy. Pediatr Cardiol 1995;16:56-60. https://doi.org/10.1007/BF00796818
15. Türe M, Balık H, Akın A, Bilici M, Nergiz A. The relationship between electrocardiographic data and mortality in children diagnosed with dilated cardiomyopathy. Eur J Pediatr 2020;179:813-819. https://doi.org/10.1007/s00431-020-03569-9
16. Manolio TA, Baughman KL, Rodeheffer R, et al. Prevalence and etiology of idiopathic dilated cardiomyopathy (summary of a National Heart, Lung, and Blood Institute workshop. Am J Cardiol 1992;69:1458-1466. https://doi.org/10.1016/0002- 9149(92)90901-a
17. Zecchin M, Lenarda AD, Bonin M, et al. Incidence and predictors of sudden cardiac death during long-term follow-up in patients with dilated cardiomyopathy on optimal medical therapy. Ital Heart J 2001;2:213-221.
18. Jefferies JL, Towbin JA. Dilated cardiomyopathy. Lancet 2010;375:752-762. https://doi.org/10.1016/ S0140-6736(09)62023-7
19. Adwani SS, Whitehead BF, Rees PG, et al. Heart transplantation for dilated cardiomyopathy. Arch Dis Child 1995;73:447-452. https://doi.org/10.1136/ adc.73.5.447